Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Mol Genet Metab. 2009 Aug 8;98(4):331–337. doi: 10.1016/j.ymgme.2009.07.016

Table 1.

Individual Characteristics of 8 Adult Subjects with PKU

Childhood tolerance
Adult tolerance
Subject/Sex Age BMIa Genotype Expected Phenotypeb Age 5c Initial Final

y kg/m2 mg phe/kg wt mg phe/kg wt mg phe/kg wt
1/M 27 24 R408W IVS12nt1g->a Classic 13 (248)d 6.9 (505) 15.7 (1149)
2/M 29 23 R261Q R408W Moderate 11.5 (215) 9.8 (658) 26.8 (1793)
6/F 23 21 R408W IVS12nt1g->a Classic 9 (151) 8.1 (423) 10.8 (550)
7/F 28 25 L242F R408W Classic 14 (241) 4.7 (304) 8.5 (545)
8/M 27 26 R261Q E280K Moderate 17 (332) 10.4 (787) 12.8 (971)
9/F 20 26 L48S F299C Mild 16 (273) 4.1 (265) 4.8 (305)
10/F 31 28 F299C R408W Classic 10.4 (179) 2.6 (188) 6.5 (457)
11/M 28 28 IVS1nt5g->t IVS12nt1g->a Classic 14.2 (310) 9.2 (840) 7.7 (697)
Meane 27 ± 1 25 ± 0.9 13.1 ± 1 7.0 ± 1.0* 11.7 ± 2.5
a

Body mass index, BMI

b

Expected phenotype based on individual mutations as described in Guldberg et al [15].

c

Childhood tolerance at age 5 based on a chart review of clinic records. All subjects were in good phe control based on an average of 2 phe concentrations within 3 months of each subject’s fifth birthday.

d

mg phe/day shown in parentheses

e

Values are mean ± SEM

*

Indicates significantly different from childhood tolerance, two-tailed paired t-test, pairing on subject; P=0.002

Indicates different from final adult tolerance; two-tailed paired t-test, pairing on subject; P=0.055